Insider Trading & Ownership - Graham G. Walmsley

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Graham G. Walmsley
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-04
Sale
2024-06-06
5:01 pm
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
1,175,000$14.85$17,448,750708,114
(Indirect)
View
2023-09-12
Purchase
2023-12-18
6:30 pm
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
640,000$10.74$6,871,2794,383,875
(Indirect)
View
2023-12-08
Purchase
2023-12-11
9:06 pm
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
100,000$19.83$1,982,940802,168
(Indirect
Direct)
View
2023-11-30
Purchase
2023-12-05
08:37 am
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
100,000$16.95$1,694,565702,168
(Indirect
Direct)
View
2023-08-08
Purchase
2023-08-10
4:46 pm
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
25,000$42.06$1,051,475602,168
(Indirect
Direct)
View
2023-07-28
Purchase
2023-08-01
7:52 pm
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
55,000$42.95$2,362,234577,168
(Indirect
Direct)
View
2022-09-19
Purchase(A)
2023-06-15
9:26 pm
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
520,000$29.69$15,440,000522,168
(Indirect
Direct)
View
2023-05-19
Purchase
2023-05-23
9:55 pm
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
520,000$29.69$15,440,000522,168
(Indirect
Direct)
View
2020-12-14
Purchase
2020-12-15
7:07 pm
ALX ONCOLOGY HOLDINGS INCALXOGraham G. Walmsley
Director
20,000$76$1,520,0003,156,981
(Indirect)
View
2020-11-23
Purchase
2020-11-23
4:35 pm
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
1,160,000$19$22,040,0001,160,000
(Indirect)
View
2020-07-21
Purchase
2020-07-21
8:04 pm
ALX ONCOLOGY HOLDINGS INCALXOGraham G. Walmsley
Director
975,000$19$18,525,000975,000
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-14
Option Award
2024-06-18
5:00 pm
N/A
2034-06-14
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
23,000$023,000
(Direct)
View
2024-06-08
Option Award
2024-06-11
5:29 pm
N/A
2034-06-07
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
26,000$026,000
(Direct)
View
2023-06-23
Option Award
2023-06-27
5:48 pm
N/A
2033-06-22
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
15,000$015,000
(Direct)
View
2023-06-16
Option Award
2023-06-21
5:00 pm
N/A
2033-06-15
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
21,520$021,520
(Direct)
View
2022-06-17
Option Award(A)
2022-06-27
5:10 pm
N/A
2032-06-16
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
21,520$021,520
(Direct)
View
2022-06-16
Option Award
2022-06-17
7:25 pm
N/A
2032-06-15
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
21,520$021,520
(Direct)
View
2022-06-02
Option Award
2022-06-03
4:06 pm
N/A
2032-06-01
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
15,000$015,000
(Direct)
View
2021-06-11
Option Award
2021-06-15
7:03 pm
N/A
2031-06-10
ALX ONCOLOGY HOLDINGS INCALXOGraham G. Walmsley
Director
12,004$012,004
(Direct)
View
2021-06-09
Option Award
2021-06-10
6:38 pm
N/A
2031-06-08
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
21,520$021,520
(Direct)
View
2021-06-01
Option Award
2021-06-03
5:55 pm
N/A
2031-05-31
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
13,000$062,832
(Direct)
View
2021-06-01
Gift
2021-06-03
5:55 pm
N/A
2031-05-31
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
49,832$062,832
(Direct)
View
2020-11-23
Conversion
2020-11-23
4:35 pm
N/A
N/A
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
2,583,875$01,160,000
(Indirect)
View

Ownership
2020-11-20
7:06 pm
N/A
N/A
Lifesci Acquisition II Corp.LSAQGraham G. Walmsley
Director
0$06,000
(Direct)
View
2020-11-18
Option Award
2020-11-19
7:01 pm
N/A
2030-11-17
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
64,560$01,587,252
(Direct)
View

Ownership
2020-11-18
6:41 pm
N/A
N/A
Olema Pharmaceuticals Inc.OLMAGraham G. Walmsley
Director
0$02,583,875
(Indirect)
View
2020-07-21
Conversion
2020-07-21
8:04 pm
N/A
N/A
ALX ONCOLOGY HOLDINGS INCALXOGraham G. Walmsley
Director
2,105,901$0975,000
(Indirect)
View
2020-07-16
Option Award
2020-07-17
7:10 pm
N/A
2030-07-16
ALX ONCOLOGY HOLDINGS INCALXOGraham G. Walmsley
Director
24,009$024,009
(Direct)
View

Ownership
2020-07-16
6:41 pm
N/A
N/A
ALX ONCOLOGY HOLDINGS INCALXOGraham G. Walmsley
Director
0$02,105,901
(Indirect)
View
2020-06-01
Option Award
2020-06-02
6:53 pm
N/A
2030-05-31
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
13,000$013,000
(Direct)
View
2020-03-30
Exercise
2020-04-01
6:52 pm
N/A
N/A
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
2,168$19.9726,000
(Direct)
View
2019-11-08
Exercise
2020-04-01
6:52 pm
N/A
2029-11-07
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
2,168$026,000
(Direct)
View
2019-11-08
Option Award
2019-11-12
7:02 pm
N/A
2029-11-07
Akero Therapeutics Inc.AKROGraham G. Walmsley
Director
26,000$026,000
(Direct)
View
(A) Indicate amendment filing.